# Cannabis Use and Trauma-Focused Treatment for PTSD & Substance Use > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd-meta-analysis/ > **Published:** 2026-03-16T20:14:00-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:06:27-04:00 > **Clinical Summary:** Explore cannabis use trauma-focused treatment PTSD in co-occurring substance use disorders and its impact on evidence-based PTSD interventions. --- #### Clinical Takeaway People with PTSD and co-occurring [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) who use cannabis can still benefit meaningfully from trauma-focused treatments. [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) does not appear to prevent or significantly undermine the effectiveness of evidence-based PTSD therapies in this population. ### #6 Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data. **Citation:** Hill Melanie L et al. *[Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.* Journal of [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/). 2024. PMID: 38266511. **Study type:** Meta-Analysis, Journal Article, Research Support, N.I.H., Extramural  |  **Topic area:** Anxiety & PTSD  |  **CED Score:** 12 Design: 6 Journal: 0 N: 4 Recency: 1 Pop: 2 Human: 1 Risk: -2 Why This Matters This meta-analysis addresses a critical clinical gap by examining whether evidence-based trauma-focused treatments maintain efficacy in the substantial subset of PTSD+SUD patients who use cannabis, a population often excluded from traditional efficacy trials. The findings directly inform treatment selection and sequencing decisions for dually diagnosed patients, who represent a significant proportion of clinical caseloads but lack adequate guidance on optimal intervention strategies. Understanding treatment response patterns in cannabis users with co-occurring PTSD and SUD enables clinicians to make data-driven decisions about whether to initiate trauma-focused therapy, modify dosing, or address substance use concurrently. **Quality Gate Alerts:** - Preclinical only **Abstract:** High rates of cannabis use among people with posttraumatic stress disorder (PTSD) have raised questions about the efficacy of evidence-based PTSD treatments for individuals reporting cannabis use, particularly those with co-occurring alcohol or other substance use disorders (SUDs). Using a subset of four randomized [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) (RCTs) included in Project Harmony, an individual patient meta-analysis of 36 RCTs (total N = 4046) of treatments for co-occurring PTSD+SUD, we examined differences in trauma-focused (TF) and non-trauma-focused (non-TF) treatment outcomes for individuals who did and did not endorse baseline cannabis use (N = 410; 70% male; 33.2% endorsed cannabis use). Propensity score-weighted mixed effects modeling evaluated main and interactive effects of treatment assignment (TF versus non-TF) and baseline cannabis use (yes/no) on attendance rates and within-treatment changes in PTSD, alcohol, and non-cannabis drug use severity. Results revealed significant improvements across outcomes among participants in all conditions, with larger PTSD symptom reductions but lower attendance among individuals receiving TF versus non-TF treatment in both cannabis groups. Participants achieved similar reductions in alcohol and drug use across all conditions. TF outperformed non-TF treatments regardless of recent cannabis use, underscoring the importance of reducing barriers to accessing TF treatments for individuals reporting cannabis use. Clinical Perspective While this meta-analysis contributes valuable data on an underexplored population, several important limitations warrant cautious interpretation in clinical practice. The analysis draws from only four RCTs nested within a larger project, which substantially constrains generalizability and statistical power to detect meaningful differences between cannabis users and non-users with co-occurring PTSD and SUD. The heterogeneity of cannabis use patterns, concurrent polysubstance involvement, and variations in trauma-focused treatment protocols across the included trials create confounding that is difficult to fully disentangle, and the analysis does not clarify whether cannabis use reflects self-medication, contributes to treatment dropout, or truly impairs therapeutic outcomes. Given the real-world prevalence of cannabis use in this vulnerable population and the relative scarcity of evidence-based treatment options, a null or modest finding would not necessarily justify withholding trauma-focused care from cannabis users, but rather should encourage shared decision-making about concurrent use and potentially more intensive monitoring during treatment. In practice, trauma-  |   |  Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/38266511/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138203/)[DOI ↗](https://doi.org/10.1016/j.janxdis.2024.102827) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Endocannabinoid System Research: Cannabis & PTSD Treatment](https://cedclinic.com/ptsd-cannabis-trauma-meta-analysis/) Explore research on the endocannabinoid system's role in cannabis and [PTSD treatment](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/), providing insights into therapeutic mechanisms. [Read More](https://cedclinic.com/ptsd-cannabis-trauma-meta-analysis/) [Cannabis in PTSD Treatment: Meta-Analysis of Trauma-Focused Care](https://cedclinic.com/cannabis-use-ptsd-treatment-outcomes-meta-analysis/) A detailed meta-analysis examining the effects of cannabis use on trauma-focused [PTSD treatment](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/) outcomes. [Explore Study](https://cedclinic.com/cannabis-use-ptsd-treatment-outcomes-meta-analysis/) [Endocannabinoid System Clinical Research: PTSD Treatment](https://cedclinic.com/endocannabinoid-system-clinical-research-ptsd-treatment/) [Clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) focusing on the endocannabinoid system's involvement in PTSD treatment strategies. [Learn More](https://cedclinic.com/endocannabinoid-system-clinical-research-ptsd-treatment/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Endocannabinoid%20System%20%26%20PTSD%3A%20Cannabis%20Meta-Analysis&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-trauma-focused-treatment-ptsd-meta-analysis%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-trauma-focused-treatment-ptsd-meta-analysis%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Endocannabinoid%20System%20%26%20PTSD%3A%20Cannabis%20Meta-Analysis%20https%3A%2F%2Fcedclinic.com%2Fcannabis-use-trauma-focused-treatment-ptsd-meta-analysis%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).